- Home
- EDBL vs VRAX Comparison
EDBL vs VRAX Comparison
Compare EDBL & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- VRAX
- Stock Information
- Founded
- EDBL 2020
- VRAX 2013
- Country
- EDBL United States
- VRAX United Kingdom
- Employees
- EDBL N/A
- VRAX N/A
- Industry
- EDBL Farming/Seeds/Milling
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EDBL Consumer Staples
- VRAX Health Care
- Exchange
- EDBL Nasdaq
- VRAX Nasdaq
- Market Cap
- EDBL 4.8M
- VRAX 4.7M
- IPO Year
- EDBL 2022
- VRAX 2022
- Fundamental
- Price
- EDBL $2.60
- VRAX $0.81
- Analyst Decision
- EDBL
- VRAX Strong Buy
- Analyst Count
- EDBL 0
- VRAX 1
- Target Price
- EDBL N/A
- VRAX $3.00
- AVG Volume (30 Days)
- EDBL 134.6K
- VRAX 37.2K
- Earning Date
- EDBL 08-13-2025
- VRAX 02-05-2025
- Dividend Yield
- EDBL N/A
- VRAX N/A
- EPS Growth
- EDBL N/A
- VRAX N/A
- EPS
- EDBL N/A
- VRAX N/A
- Revenue
- EDBL $13,443,000.00
- VRAX $84,872.00
- Revenue This Year
- EDBL $29.56
- VRAX $5,169.18
- Revenue Next Year
- EDBL $20.00
- VRAX $66.97
- P/E Ratio
- EDBL N/A
- VRAX N/A
- Revenue Growth
- EDBL N/A
- VRAX 7.03
- 52 Week Low
- EDBL $1.80
- VRAX $0.75
- 52 Week High
- EDBL $39.50
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- EDBL 45.24
- VRAX 31.75
- Support Level
- EDBL $2.53
- VRAX $0.75
- Resistance Level
- EDBL $2.85
- VRAX $0.85
- Average True Range (ATR)
- EDBL 0.21
- VRAX 0.07
- MACD
- EDBL -0.06
- VRAX -0.01
- Stochastic Oscillator
- EDBL 16.18
- VRAX 6.57
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.